Create

Sign in to ReadmeX

or

How we handle your data: Privacy Policy

ReadmeX

Your AI reading companion

What would you like to catch up on?

Pick a briefing, or ask your own question.

Your community and people briefings stay personal to you.

Absci

AI overview

Sign in and the AI will write an overview from our coverage.

Headlines · 1

  1. Anthropic’s biomedicine strategy targets closed-loop drug discovery

    A 36Kr review examines Anthropic’s biomedicine push, including Claude Science, the Model Hardware Standard for laboratory equipment, protein-design agents, wet-lab partnerships, and the Mithril and Coefficient Bio acquisitions. The review says Anthropic is using Claude to orchestrate molecular-design models such as BoltzGen and is building a “pipeline-in-a-person,” while wet-lab validation remains a constraint. It characterizes biomedicine as Anthropic’s next concentrated investment focus after coding and says the strategy is more focused than OpenAI’s broader life-science activities, though that comparison is editorial judgment.

    36氪 人工智能 · 🔥 0

Experience and discussion from the community

Share my Absci experienceAsk about Absci

Nobody has shared their experience with Absci yet.